Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Long-acting blood sugar decreasing fusion protein

Long-acting blood sugar decreasing fusion protein

US Patent 10017555 · Granted Jul 10, 2018

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human CD47-targeting single-domain antibody and use thereof2025
Fragmentation for measuring methylation and disease2025
Use of Rivastigmine in preparation of anti-radiation medicament2023
Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants2019
Mutated antibody of fully humanized HER2 antibody, and encoding gene and use the2019
Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants2018
Antibodies directed to angiopoietin-2 and uses thereof2018
Anti-human RANKL antibody, humanized antibody of the same, and pharmaceutical co2018
Anti-human RANKL antibody, humanized antibody of the same, and pharmaceutical co2018
Methods of treating cell culture media for use in a bioreactor2016
Antibodies directed to angiopoietin-2 and uses thereof2014
Compounds for fluorescent labeling2013